ChemicalBook > CAS DataBase List > 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine

4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine

Product Name
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
CAS No.
134965-85-8
Chemical Name
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
Synonyms
Tofacitinib-27;Tofatinib impurity 28;Tofatinib Impurity 14;Baritinib Impurity 33;Baricitinib Impurity 33;Azilsartan medoxomil impurity330;4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine;4'-Chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine;4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine;4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine
CBNumber
CB83311149
Molecular Formula
C12H7ClN6
Formula Weight
270.68
MOL File
134965-85-8.mol
More
Less

4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Property

Boiling point:
397.4±52.0 °C(Predicted)
Density 
1.74±0.1 g/cm3(Predicted)
pka
10.39±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P501Dispose of contents/container to..…

More
Less

4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Chemical Properties,Usage,Production

Uses

4'-chloro-7H-4,7h'-pyrrolo[2,3-d]pyrimidine is a Baricitinib and tofacitinib impurity reference substance. It could be used for new drug research and experimental use.

4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Suppliers

China 53 India 2 United States 1 Global 56
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58
More
Less

View Lastest Price from 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Baricitinib Impurity 33 134965-85-8
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-04-07
ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Baricitinib Impurity 33 134965-85-8
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-04-26
ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Tofacitinib Impurity 14 134965-85-8
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-05-17

134965-85-8, 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidineRelated Search:

7H-Pyrrolo[2,3-d]pyrimidine, 4-hydrazinyl- Tofacitinib impurity T 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]- Tofacitinib Impurity 45 Ethyl S-4-chloro-3-hydroxybutyrate 2-amino-4-fluoro-5-nitrobenzoic acid (3R,4R)-N,4-dimethyl-piperidin-3-amine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine Tofacitinib Impurity 20 R-afatinib 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 19 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine

  • 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine
  • Tofacitinib impurity 21/4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
  • Tofacitinib-27
  • 4,7'-Bi-7H-pyrrolo[2,3-d]pyrimidine, 4'-chloro-
  • 4-chloro-7-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-7H-pyrrolo[2,3-d]pyrimidine
  • Azilsartan medoxomil impurity330
  • Tofacitinib Related Compound 29Q: What is Tofacitinib Related Compound 29 Q: What is the CAS Number of Tofacitinib Related Compound 29
  • 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine(Tofacitinib impurity )
  • 4-chloro-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolo[2,3-d]pyrimidine
  • Tofatinib Impurity 14
  • Tofatinib impurity 28
  • 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
  • 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine
  • 4'-Chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
  • Baricitinib Impurity 33
  • Baritinib Impurity 33
  • 134965-85-8